| |
|
InnoMed Technologies
vs Cardinal Health
InnoMed Technologies Inc. Files Motion to Include Cardinal Health in Lawsuit.
InnoMed and Mergenet filed a motion with the Court, on June 13, 2009,
seeking to amend its counterclaim to add additional claims, and an
additional plaintiff, Mergenet, and an additional counterdefendant, Cardinal
Health Inc., Viasys' parent and a billion dollar publicly traded
corporation. As noted, Viasys allegedly was primarily responsible for the
funding of the ill-conceived Harmon litigation in exchange for a
royalty-bearing license in the InnoMed patents, had Harmon been successful
in his suit. The proposed amendment includes claims against all
counterdefendants for civil conspiracy, champerty and maintenance, fraud and
fraud in the inducement, slander of title and commercial disparagement to
its patents, tortious interference with business relationships, malicious
prosecution, and breach of contract. Since 2002, the company have been
embroiled in litigation with Kevin Harmon, a plaintiff, who has claimed,
among other things, that InnoMed had misappropriated the rights to, and was
not a bona fide purchaser of, the patents pertaining to the so-called Nasal
Aire sleep apnea device when InnoMed acquired such patents as part of an
asset purchase in April 2001. Specifically, the Harmon litigation claimed
that InnoMed participated with others in the conversion and fraudulent
conveyance of the patents. In addition Harmon requested an accounting and
sought unjust enrichment damages. On January 27, 2009, the Superior Court in
Waycross, Georgia, dismissed all of the Harmon claims in response to the
motion for summary judgment.
|
|
|